Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

August 22, 2014
Bioniche Life Sciences Announces Terms of $5 Million Financing & Use of Proceeds

August 21, 2014
Bioniche Life Sciences Announces Overnight Marketed Offering

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Corporate

August 2014

21/08/14
Bioniche Life Sciences Announces Overnight Marketed Offering

June 2014

13/06/14
Bioniche Life Sciences Inc. to Present at Bloom Burton & Co. Healthcare Investor Conference

03/06/14
Bioniche Provides Corporate Update

April 2014

15/04/14
Vétoquinol and Bioniche Life Sciences Inc. Close Sale of Bioniche Animal Health Business

14/04/14
Bioniche Life Sciences Inc. Shareholders Approve Sale of Animal Health Business

03/04/14
ISS Recommends that Bioniche Shareholders Vote in Favour of Animal Health Sale Transaction

03/04/14
Bioniche Life Sciences Inc. Continues to Execute on Strategic Review

March 2014

13/03/14
Bioniche Life Sciences Inc. Holds Shareholder Conference Call/Webcast

04/03/14
Bioniche Life Sciences Inc. Announces Key Corporate Updates

January 2014

07/01/14
Bioniche Life Sciences Inc. Appoints a Chief Operating Officer

November 2013

04/11/13
Bioniche Life Sciences Inc. Announces the Appointment of a New Chief Executive Officer

October 2013

07/10/13
Bioniche Provides an Update on Plans for a New Drug Submission Filing in Canada

September 2013

11/09/13
Bioniche Founder and CEO Announces his New Role with the Company

July 2013

23/07/13
Ontario Court Confirms Timing of Bioniche’s Annual Meeting of Shareholders

05/07/13
Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin™ Licensing Deals

June 2013

27/06/13
Bioniche Life Sciences Inc. to Provide an Update on Vaccine Manufacturing Centre Validation

12/06/13
Bioniche Founder and CEO Addresses Shareholders

May 2013

29/05/13
Bioniche Responds to Dissident Shareholders and Rejects Call for Early Shareholder Meeting

April 2013

22/04/13
Bioniche Life Sciences Inc. Responds to Letter from Former Biovail Executives

January 2013

30/01/13
Bioniche Life Sciences Inc. Terminates its License Agreement with Trophogen Inc.

December 2012

06/12/12
Bioniche Life Sciences Inc. Announces a Change to its Board of Directors

July 2012

30/07/12
Bioniche Life Sciences Inc. Appoints an Independent Chairman of its Board of Directors

November 2011

09/11/11
Bioniche Life Sciences Inc. Holds Annual & Special Meeting of Shareholders

October 2011

20/10/11
New York Court Grants Summary Judgment in Favour of Bioniche Life Sciences Inc.

September 2011

29/09/11
Bioniche Life Sciences Inc. Launches Three New Products

August 2011

01/08/11
Bioniche Life Sciences Inc. Will Not Proceed With Business and Asset Acquisition of Plasvacc Holdings Limited

July 2011

04/07/11
Bioniche Life Sciences Inc. has Agreed to Acquire Plasvacc Holdings Limited of Australia

March 2011

31/03/11
Folltropin®-V - a Key Bioniche Animal Health Product - Receives Marketing Authorization in China

January 2011

03/01/11
Bioniche Announces Reorganization of Leadership Team

December 2010

21/12/10
Bioniche Animal Health and IMV Technologies Sign European Distribution Agreement

06/12/10
Bioniche, Through Distributor, Provides Exclusive Supply to Angus Association in Australia

October 2010

28/10/10
Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada for a Second Time

August 2010

25/08/10
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

June 2010

17/06/10
Bioniche Strengthens its International Patent Portfolio for its MCC & Oligonucleotide Technology Platforms

April 2010

19/04/10
Bioniche Receives FedDev Ontario Investment to Support Fermentation Scale-Up for New Vaccine Manufacturing Centre

August 2009

05/08/09
Bioniche Announces Resignation of its CFO

June 2009

22/06/09
Bioniche Provides a Corporate Update

April 2009

27/04/09
Bioniche Provides a Corporate Update

May 2008

23/05/08
Bioniche Presents Pre-Clinical Research at Two International Conferences

April 2008

18/04/08
Bioniche Reports the Passing of its Board Chair

February 2008

08/02/08
Bioniche Receives $5 Million Capital Financing Support to Scale-up E. coli O157:H7 Vaccine Production

December 2007

20/12/07
Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario

18/12/07
Bioniche Receives $10 Million of Provincial Government Support to Scale-up Vaccine Production in Ontario

17/12/07
Announcement Planned by Ontario Ministry of Economic Development and Trade

04/12/07
Bioniche Recognized as One of the Top 10 Life Science Companies in Canada

November 2007

15/11/07
Bioniche Presents at Annual Convention of Canadian Association of Fairs & Exhibitions

06/11/07
Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference

October 2007

05/10/07
Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial

04/10/07
Bioniche to Present at BioContact Quebec 2007

September 2007

10/09/07
Bioniche Reaches Special Protocol Assessment Agreement with U.S. FDA for Phase III Comparative Bladder Cancer Trial

July 2007

19/07/07
Bioniche Appoints New Animal Health and Food Safety Leadership Team

18/07/07
Bioniche Appoints New Director to its Board

May 2007

01/05/07
Bioniche E. coli O157:H7 Vaccine Discussed at 4th International Conference on Vaccines for Enteric Diseases

March 2007

30/03/07
Bioniche Recognized with Québec Biotechnology Award

29/03/07
Bioniche and Technology Partnerships Canada Amend Agreement on MCC Research Project

02/03/07
Bioniche Files Final Short-Form Prospectus for Offering of Units

February 2007

09/02/07
Bioniche Files Preliminary Short-Form Prospectus for Offering of Units

January 2007

12/01/07
Bioniche Further Pays Down Debt with Laurus Master Funds

December 2006

22/12/06
Bioniche Further Pays Down Debt

08/12/06
Bioniche Completes Sale of Two Remaining Assets Associated with Irish Pharma Group

November 2006

07/11/06
Bioniche Plans to Liquidate Two Remaining Assets Associated with Irish Pharma Group

October 2006

31/10/06
Bioniche to Present at Rodman & Renshaw 8th Annual Healthcare Conference

02/10/06
Bioniche Board Approves a Shareholders Rights Plan

September 2006

29/09/06
Bioniche Life Sciences Inc. Re-Files its 2005 MD&A and Certificates

June 2006

27/06/06
Cameron Groome Joins Bioniche as Executive Vice-President, Corporate & Strategic Development

March 2006

22/03/06
Updates on MCC Phase III Bladder Cancer Study and E. coli O157:H7 Cattle Vaccine Regulatory Progress

February 2006

01/02/06
Bioniche and RoundTable Healthcare Partners Close Sale of Bioniche Pharma Group Ltd.

January 2006

12/01/06
Bioniche Signs Definitive Purchase Agreement for Sale of Pharma Group to RoundTable Healthcare Partners

October 2005

28/10/05
Bioniche Clarifies Terms of Pharma Group Sale and Private Placement

18/10/05
Bioniche Pharma Group and AngioDynamics Sign Exclusive Distribution Agreement for Sotradecol(R) Injection

05/10/05
Bioniche and ICC Private Equity Fund Agree to Sell Bioniche Pharma Group to RoundTable Healthcare Partners

04/10/05
Bioniche Retains Blackmont Capital to Assist in the Sale of its Pharma Business Unit

September 2005

26/09/05
Bioniche in Good Standing with Technology Partnerships Canada (TPC)

July 2005

12/07/05
Bioniche Reports Positive News from BetacTM Product Recall Investigation

June 2005

20/06/05
Bioniche Life Sciences Retains GCI Group as Strategic Investor Relations Counsel

13/06/05
Bioniche Appoints New Chief Medical Officer to Advance Clinical Trials

01/06/05
Bioniche Pharma Group and Grünenthal Sign Exclusive Agreement for Distribution of Suplasyn®

May 2005

17/05/05
Bioniche Granted Additional Patent for Mycobacterial Cell Wall Technology

13/05/05
Bioniche Announces Change in Board of Directors Composition

04/05/05
Bioniche to Present at Rodman & Renshaw

March 2005

29/03/05
Bioniche Granted European Patent for MCC in Bladder Cancer

22/03/05
Bioniche Presents Further Data on Mycobacterial Cell Wall-DNA Complex (MCC) at European Association of Urology 20th Congress

December 2004

23/12/04
Bioniche Animal Health Appoints New Leaders of European and Australian/Asian Operations

06/12/04
Senior Personnel Change at Bioniche

November 2004

18/11/04
New Data Confirms Unique Anticancer Activity Profile

08/11/04
New Studies Demonstrate Anti-Cancer Activity of Bioniche Technology Against Canine Cancer

04/11/04
Bioniche Reports First Quarter Results for Fiscal 2005

October 2004

06/10/04
Bioniche Expands its Intellectual Property Portfolio

September 2004

23/09/04
Bioniche Presents Data on Cystistat and Launches Product Web Site at Inaugural Multinational Interstitial Cystitis Association Annual Meeting

20/09/04
Bioniche Appoints a Chief Operating Officer

August 2004

26/08/04
Bioniche Ranked Among the Top 100 Global Biotechnology Companies by Med Ad News

June 2004

14/06/04
Bioniche Serves Community Needs Through New Pet Loss Program

08/06/04
Bioniche Ranked Among Canada’s Top 100 Fastest-Growing Companies by PROFIT Magazine

01/06/04
Bioniche Retains The Anne McBride Company Inc.


Newsroom

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy